NEJM - "Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults"

"Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults"

"CONCLUSIONS

Among older adults, PCV13 was effective in preventing vaccine-type pneumococcal, bacteremic, and nonbacteremic community-acquired pneumonia and vaccine-type invasive pneumococcal disease but not in preventing community-acquired pneumonia from any cause. (Funded by Pfizer; CAPITA ClinicalTrials.gov number NCT00744263.)"

http://www.nejm.org/doi/full/10.1056/NEJMoa1408544?query=featured_home